A RETROSPECTIVE STUDY ON EFFECTS OF SERUM CHOLESTEROL ON MORTALITY AND MORBIDITY OF STROKE

Cite this:
[1]
Dr. Sona Priya P*, Dr. Madhan R, Dr. Shamini AK, Dr. Navin Frank, Dr. S Thilagar, MD, “A RETROSPECTIVE STUDY ON EFFECTS OF SERUM CHOLESTEROL ON MORTALITY AND MORBIDITY OF STROKE”, ijmhs, vol. 9, no. 12, pp. 697–701, Dec. 2019.
© 2022 Interactive Protocols
Article Views
305
Altmetric
1
Citations
-

Abstract

Introduction:
Stroke or cerebrovascular accident or Intracranial Hemorrhage (ICH) is defined
as an abrupt onset of a neurological deficit that is attributable to a focal vascular
cause. Stroke is the second leading cause of death worldwide causing 6.2
million deaths in 2011. Relation of high total cholesterol and triglycerides with
ischemic heart disease is well established worldwide. High cholesterol level are
estimated to cause 56% of ischemic heart disease. However, dyslipidemia as a
risk factor for ischemic stroke has been quite controversial in recent times. It
has been observed in several studies that higher cholesterol and triglyceride
levels are associated with better outcome after ischemic stroke.
Aim:
The purpose of this study is to determine the effects of serum cholesterol on the
mortality and morbidity of stroke.
MaterialsandMethod:
We retrospectively included 100 consecutive patients over age 18 with Stroke
or cerebrovascular accident or Intracranial Hemorrhage (ICH) who were
admitted in Sree Mookambika Institute of Health Sciences, confirmed by CT
within 12 hours after onset. Patients with traumatism, brain tumor, previous
ICH, hemorrhagic transformation of ischemic stroke, vascular cerebral
malformations, and patients who required neurosurgical procedures were
excluded. Data was collected with meticulous history, clinical examination with
detailed neurological examinations along with appropriate investigations. A
structured questionnaire was used to obtain data on family history of diabetesmellitus, history of hypertension, past and present illness, dietary pattern,
addiction and medication. NIH stroke scale (NIHSS) were evaluated at
admission. Descriptive and analytical statistics were performed by SPSS
version 16.IEC clearance and a written informed consent were obtained from
patient or patients attenders. A P value of less than 0.05 was considered
statistical significant.
Results:
Out of the 100 patients that were included in the study, the average age was 58.6
± 12.15. Male to female ratio was 3:1(75:25) which clearly states that men are
more prone to develop stroke compared to females. Among the patients who had
stroke, risk factors like hypercholesterolemia(75%), hypertension(65%),
diabetes mellitus(24%), smoking(40%), alcoholism(40%) were identified.
Regarding the stroke severity, 39% of the patients had a minor stroke, 44% had
a moderate intensity stroke while 17% of the patient had a severe stoke. A high
morbidity rate i.e., 80% was seen in patients who had had high total
cholesterol(75%) then compared to patients who had normal lipid profile with a
significant p value (<0.02).Only 2 passed away who was also found to have high
cholesterol and triglycerides.
Conclusion:
Our study concluded a positive correlation between serum total cholesterol.
Thus early detection of dyslipidemia and treatment with drugs along with
dietary modifications & lifestyle changes can reduce the risk of stroke.
Keywords: ICH, Stroke, Total Cholesterol, Cerebrovascular accident

 

 Special Issue

References

1.World Health Organization. Mackay J,Mensah GA. The Atlas of Heart Diseaseand Stroke [Homepage on the Internet].2004 [Published on 2004 Sep 23; cited2010 Jul 10]Availablefrom http://www.who.int/cardiovascular _diseases/resources/atlas/en/. 2.Thrift AG, Arabshahi S. Is strokeincidence in low- to middle incomecountries driven by economics? Int J Stroke. 2012;7: 307-8 3.Central Bureau of Health Intelligence.National Health Profile. New Delhi:Directorate General of Health Sciences;2008:102 4.Sreedhar K, Srikant B, Joshi L, Usha G.Lipid profile in non-diabetic stroke-astudy of 100 cases. J Assoc PhysiciansIndia 2010;58:547-51. 5.Wolf PA, Kannel WB, Dawber TR.Prospective investigation: theFramingham study and the epidemiologyof stroke. Adv Neurol 1978;19:107-20., 6.Frank JW, Reed DM, Grove JS, et al.Will lowering population level of serumcholesterol affect total mortality? J ClinEpidemiol 1992;45:333-46. 7.Iso H, Jacobs D, Wentworth D, et al.Serum cholesterol levels and 6 yearmortality from stroke in 350 977 menscreened from the multiple risk factorintervention trial. N Engl J Med 1989;320:904-10. 8.Westlund K, Nicolaysen R. Ten yearmortality and morbidity related to serumcholesterol. J Clin Lab Invest1972;127(suppl):1–24.). 9.Richardson J, Murray D, House KC,Lowenkopf T. Successful implementationof the National Institutes of Health StrokeScale on a stroke/neurovascular unit.Journal of Neuroscience Nursing2006;38(4):309-14 10.Khan J, Rehman A. Comparison ofclinical diagnosis with computedtomography in ascertaining type ofstroke. J Ayub Med Coll Abbottabad.2005;17(3):65-7. and 11.Sreedhar K, Srikant B, Joshi L, Usha G.Lipid profile in non-diabetic stroke-astudy of 100 cases. J Assoc PhysiciansIndia. 2010;58:547-51. 12.Bhalla D, Marin B, Preux PM. Strokeprofile in Afghanistan and Nepal. NeurolAsia. 2009;14:87-94. 13.Mumtaz AM, Muhammad U,Muhammad H. Stroke and its relationshipto risk factors. GJMS. 2009;7(1):169-75. 14.Qizilbash N, Duffy SW, Warlow C, et al.Lipids are risk factors for ischaemicstroke: overview and review.Cerebrovasc Dis 1992;2:127–36 15.Lindenstrom E, Boysen G, Nyboe J.Influence of total cholesterol, highdensity lipoprotein cholesterol, andtriglyceride on risk of cerebrovasculardisease. BMJ 1994;309:11– 15 16.Gaziano TA, Gaziano JM. Epidemiologyof cardiovascular disease. In: Fauci AS,Braunwald E, Kasper DL, Hauser SL,Longo DL, Jameson JL, Loscalzo J,editors. Harrison's Principles of InternalMedicine. New York: Mc Graw Hill:2008; p. 1375-9.

Article Metrics Graph

Content

Section

References

1.World Health Organization. Mackay J,Mensah GA. The Atlas of Heart Diseaseand Stroke [Homepage on the Internet].2004 [Published on 2004 Sep 23; cited2010 Jul 10]Availablefrom http://www.who.int/cardiovascular _diseases/resources/atlas/en/.
2.Thrift AG, Arabshahi S. Is strokeincidence in low- to middle incomecountries driven by economics? Int J Stroke. 2012;7: 307-8
3.Central Bureau of Health Intelligence.National Health Profile. New Delhi:Directorate General of Health Sciences;2008:102
4.Sreedhar K, Srikant B, Joshi L, Usha G.Lipid profile in non-diabetic stroke-astudy of 100 cases. J Assoc PhysiciansIndia 2010;58:547-51.
5.Wolf PA, Kannel WB, Dawber TR.Prospective investigation: theFramingham study and the epidemiologyof stroke. Adv Neurol 1978;19:107-20.,
6.Frank JW, Reed DM, Grove JS, et al.Will lowering population level of serumcholesterol affect total mortality? J ClinEpidemiol 1992;45:333-46.
7.Iso H, Jacobs D, Wentworth D, et al.Serum cholesterol levels and 6 yearmortality from stroke in 350 977 menscreened from the multiple risk factorintervention trial. N Engl J Med 1989;320:904-10.
8.Westlund K, Nicolaysen R. Ten yearmortality and morbidity related to serumcholesterol. J Clin Lab Invest1972;127(suppl):1–24.).
9.Richardson J, Murray D, House KC,Lowenkopf T. Successful implementationof the National Institutes of Health StrokeScale on a stroke/neurovascular unit.Journal of Neuroscience Nursing2006;38(4):309-14
10.Khan J, Rehman A. Comparison ofclinical diagnosis with computedtomography in ascertaining type ofstroke. J Ayub Med Coll Abbottabad.2005;17(3):65-7. and
11.Sreedhar K, Srikant B, Joshi L, Usha G.Lipid profile in non-diabetic stroke-astudy of 100 cases. J Assoc PhysiciansIndia. 2010;58:547-51.
12.Bhalla D, Marin B, Preux PM. Strokeprofile in Afghanistan and Nepal. NeurolAsia. 2009;14:87-94.
13.Mumtaz AM, Muhammad U,Muhammad H. Stroke and its relationshipto risk factors. GJMS. 2009;7(1):169-75.
14.Qizilbash N, Duffy SW, Warlow C, et al.Lipids are risk factors for ischaemicstroke: overview and review.Cerebrovasc Dis 1992;2:127–36
15.Lindenstrom E, Boysen G, Nyboe J.Influence of total cholesterol, highdensity lipoprotein cholesterol, andtriglyceride on risk of cerebrovasculardisease. BMJ 1994;309:11– 15
16.Gaziano TA, Gaziano JM. Epidemiologyof cardiovascular disease. In: Fauci AS,Braunwald E, Kasper DL, Hauser SL,Longo DL, Jameson JL, Loscalzo J,editors. Harrison's Principles of InternalMedicine. New York: Mc Graw Hill:2008; p. 1375-9.

Source